Therapeutic Focus Brill Pharma specializes in dermatology and ophthalmology, presenting a targeted opportunity to cross-sell complementary dermatology and ocular care products to healthcare providers and pharmacies within Spain and expanding to Iberian American markets.

Distribution Strength With an established sales network and exclusive distribution for HYLO products in Spain, Brill Pharma offers a ready channel for launching additional ophthalmic therapies and pairings with Ursapharm or similar high-value brands.

Academic Collaboration Their openness to physician-led research projects that Brill Pharma could develop and commercialize creates a pathway for co-developed clinical programs and sponsored studies that can generate co-branded product opportunities.

Growth Ambitions Plans to introduce high value-added products and expand into Iberian American markets indicate potential for regional expansion partnerships, regional regulatory support, and market-entry collaborations.

Strategic Partners Brill Pharma has existing partnerships and exposure through aligations with Alimera Sciences and ongoing events in ophthalmology, suggesting opportunities for co-marketing, distribution agreements, and access to established ophthalmic portfolios.